Healthcare and Life Sciences
Demographic and lifestyle trends are driving a long-term increase in demand for health services, which is creating both opportunities and challenges for Health, Social Care and Life Sciences companies.
These trends present scope for care providers to deliver enhanced consumer choice and patient outcomes, and for service and technology providers to offer value-added, cost-effective solutions that support the broader health economy.
Bowmark is one of the most experienced private equity investors in the UK Healthcare sector. In particular, we recognise the responsibilities that come with investing in this area. Achieving the highest quality standards is the single most important aspect of any growth strategy. We invest in companies that are quality-led, deliver best-in-class services and consistently contribute to positive health outcomes.
IVF treatment group Care Fertility added clinics across the UK and Ireland, while staying at the forefront of new technology and achieving industry-leading patient outcomes
Specialist neuro-rehabilitation provider Glenside expanded the scale and scope of its services while achieving high ratings from the CQC
Elderly residential care provider Healthcare Homes expanded its estate and domiciliary care business, while achieving excellent ratings for the quality of its care
Under our ownership, Datix rolled-out its patient safety and risk management software to public and private healthcare organisations across the US, Europe and Australia
Kisimul School Group
Specialist education and care provider Kisimul expanded its capacity fivefold, while achieving industry-leading ratings for the quality of its provision
Advanced Childcare significantly expanded its estate while achieving industry-leading ratings for the quality of its care and education
The Regard Partnership
Through acquisitions and a transformational merger, Regard extended its geographic reach and helped more people with learning disabilities to become independent